Pharmaceutical Companies and the Changing Face of India

2min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores the consolidation of pharmaceutical companies through mergers and acquisitions, and delves into the challenges of developing weight-loss drugs. It also sheds light on the lucrative fertility clinic industry in India through the story of Maya, a woman who faced infertility for a decade.

Chancellor Jeremy Hunt raised the prospect of the Bank of England reducing interest rates in 2024 in an interview with the FT, and Novo Nordisk’s drugs for obesity could have a profound effect on healthcare, society and our relationship with food. Plus, part three or our three-part series on a changing India looks at the country’s booming fertility industry.

Mentioned in this podcast:

FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk

Jeremy Hunt raises prospect of Bank of England rate cuts in 2024

Credit: Vogue.com

Credit: Jimmy Kimmel Live

The FT News Briefing is produced by Fiona Symon, Sonja Hutson, Kasia Broussalian and Marc Filippino. Additional help by Breen Turner, Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Our engineer is Monica Lopez. Topher Forhecz is the FT’s executive producer. The FT’s global head of audio is Cheryl Brumley. The show’s theme song is by Metaphor Music.

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.